{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-008782","form_type":"8-K","ticker":"SIGA","cik":"0001010086","company_name":"SIGA TECHNOLOGIES INC","filed_at":"2026-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.393011+00:00","generated_at":"2026-05-15T15:24:59.714822+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"SIGA 2025 product revenue $88M, down 34% YoY; net income $23.3M vs $59.2M","bullets":["Product revenues of $88M in 2025, down from $133M in 2024; total revenues $94.6M.","Net income of $23.3M ($0.32 diluted EPS) vs $59.2M ($0.82) in 2024.","Q4 product sales fell to $2.2M from $79.8M; operating loss of $9.5M.","Received $13M international order for oral TPOXX in Jan 2026; delivery expected in 2026.","BARDA 19C contract added $27M in development funding for pediatric program and manufacturing."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-008782","json":"https://secwatch.observer/filing/0001140361-26-008782.json","markdown":"https://secwatch.observer/filing/0001140361-26-008782.md","text":"https://secwatch.observer/filing/0001140361-26-008782.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1010086/000114036126008782/0001140361-26-008782-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1010086/000114036126008782/ef20067458_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T15:24:59.714822+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}